16 results
·
29ms
·
Sources: EU EUDAMED, US FDA
OHMEDA MEDICAL GIRAFFE OMNIBED
FDA 510(k)
FDA Class 2
·General Hospital
KMEDIC
FDA UDI
TELEFLEX INCORPORATED·24026704292893·
NA
FDA UDI
KEY SURGICAL, INC.·10849771049217·K-Wires, Single trocar, .062-inch (1.6mm) diame...
mahe medical GmbH
FDA UDI
mahe medical gmbh·04050659484436·K-Wire w. trocar/round end _x000D_...
K-Wire w. trocar/round end 1.57mm/127mm, 6 pcs./unit
FDA UDI
mahe medical gmbh·EMAHKM711750·K-Wire w. trocar/round end
1.57mm...
CONMED
FDA UDI
Conmed Corporation·10845854008973·OSCILLATOR ABRADER BLADE, 20 X 46 MM
W.O.M. LASER U100
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
SERAGARD VASCULAR ACCESS PATCH
FDA 510(k)
FDA Class 2
·General Hospital
SPECTRA WAVEWRITER?
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION CORPORATION·Product code LGW·February 2, 2026
DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code QBJ·March 26, 2025
COAGUCHEK ® XS SYSTEM
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS·Product code GJS·April 22, 2013
ECHELON
FDA Adverse Event
Injury
·SMITH & NEPHEW, ORTHOPEDICS·Product code JDH·April 27, 2011
GE OEC 9800
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEM INC.·Product code JAA·July 10, 2008
APPLIANCE, FIXATION, SPINAL INTERLAMINAL
FDA Adverse Event
Injury
·SYNTHES USA·Product code KWP·May 13, 2016
APPLIANCE, FIXATION, SPINAL INTERLAMINAL
FDA Adverse Event
Injury
·SYNTHES USA·Product code KWP·May 13, 2016
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012